Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer.
about
The fate of chemoresistance in triple negative breast cancer (TNBC)Body Mass Index with Tumor 18F-FDG Uptake Improves Risk Stratification in Patients with Breast CancerImaging findings of invasive micropapillary carcinoma of the breastExpression of centromere protein F (CENP-F) associated with higher FDG uptake on PET/CT, detected by cDNA microarray, predicts high-risk patients with primary breast cancer.Prognostic Value of Primary Tumor Uptake on F-18 FDG PET/CT in Patients with Invasive Ductal Breast Cancer(18)F-FDG PET/CT Findings in a Breast Cancer Patient with Concomitant Tuberculous Axillary Lymphadenitis.FDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma.Prognostic implication of intratumoral metabolic heterogeneity in invasive ductal carcinoma of the breast.Clinical value of F-FDG PET/CT in assessing suspicious relapse after rectal cancer resectionPositron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imagingRegulation of the Warburg effect in early-passage breast cancer cells.PET tumor metabolism in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy: value of static versus kinetic measures of fluorodeoxyglucose uptake.Standardized uptake value of ¹⁸F-fluorodeoxyglucose positron emission tomography for prediction of tumor recurrence in breast cancer beyond tumor burden.Clinicopathological and prognostic impact of imaging of breast cancer angiogenesis and hypoxia using diffuse optical spectroscopy.Correlation between PET/CT results and histological and immunohistochemical findings in breast carcinomasCorrelation of Primary Tumor FDG Uptake with Clinicopathologic Prognostic Factors in Invasive Ductal Carcinoma of the BreastAssociations between the standardized uptake value of (18)F-FDG PET/CT and the prognostic factors of invasive lobular carcinoma: in comparison with invasive ductal carcinoma.Axillary Lymph Node-to-Primary Tumor Standard Uptake Value Ratio on Preoperative (18)F-FDG PET/CT: A Prognostic Factor for Invasive Ductal Breast Cancer.A case of early stage lung cancer detected by repeated cancer screening with positron emission tomographyMetabolomics of Breast Cancer Using High-Resolution Magic Angle Spinning Magnetic Resonance Spectroscopy: Correlations with 18F-FDG Positron Emission Tomography-Computed Tomography, Dynamic Contrast-Enhanced and Diffusion-Weighted Imaging MRIA case of primary lung cancer lesion demonstrated by F-18 FDG positron emission tomography/computed tomography (PET/CT) one year after the detection of metastatic brain tumorDiffusion-weighted imaging and FDG PET/CT: predicting the prognoses with apparent diffusion coefficient values and maximum standardized uptake values in patients with invasive ductal carcinoma.Oestrogen-related tumour phenotype: positron emission tomography characterisation with ¹⁸F-FDG and ¹⁸F-FESEvaluation of the association between HIF-1α and HER-2 expression, hormone receptor status, Ki-67 expression, histology and tumor FDG uptake in breast cancer.18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterizationPrognostic value of quantitative fluorodeoxyglucose measurements in newly diagnosed metastatic breast cancer.Initial Fludeoxyglucose (18F) Positron Emission Tomography-Computed Tomography (FDG-PET/CT) Imaging of Breast Cancer - Correlations with the Primary Tumour and Locoregional Metastases.Preoperative 18F-FDG PET/CT predicts disease-free survival in patients with primary invasive ductal breast cancer.Correlation of breast cancer subtypes, based on estrogen receptor, progesterone receptor, and HER2, with functional imaging parameters from ⁶⁸Ga-RGD PET/CT and ¹⁸F-FDG PET/CT.18F-FDG uptake in breast cancer correlates with immunohistochemically defined subtypes.Present and future role of FDG-PET/CT imaging in the management of breast cancer.Measuring relative utilization of aerobic glycolysis in breast cancer cells by positional isotopic discrimination.Differentiation of tumor sensitivity to photodynamic therapy and early evaluation of treatment effect by nuclear medicine techniques.The Prognostic Value of (18)F-FDG PET/CT for Early Recurrence in Operable Breast Cancer: Comparison with TNM Stage.Dual-Time 18F-FDG PET/CT Imaging in Initial Locoregional Staging of Breast Carcinoma: Comparison with Conventional Imaging and Pathological Prognostic Factors.(18)F-FDG PET/CT of advanced gastric carcinoma and association of HER2 expression with standardized uptake value.Factors Associated with (18)F-Fluorodeoxyglucose Uptake in T1 and T2 Invasive Ductal Carcinoma of the Breast.Correlation between 18F-FDG Positron-Emission Tomography 18F-FDG Uptake Levels at Diagnosis and Histopathologic and Immunohistochemical Factors in Patients with Breast Cancer.Usefulness of (18)F-FDG positron emission tomography/computed tomography for the diagnosis of pyothorax-associated lymphoma: A report of three cases.Molecular subtypes of breast cancer: metabolic correlation with ¹⁸F-FDG PET/CT.
P2860
Q26775232-6703C79C-6027-4037-914B-4E1C12887A9BQ28109681-C0F0C2BA-092A-4B44-83C6-53083A1899ABQ30468667-D19F4C27-0383-473D-9128-678BF83B3DF9Q33395114-ECC996E7-8075-4FC7-A177-6E5276798E95Q33704435-C4751CE9-1AD7-45BF-9FC5-696AA4EB61CAQ33704463-11EE78E6-885C-4832-8FD3-F1E5AAD2D127Q33724626-EF8DD51F-2A1A-4457-89EA-93C5A663AB4AQ34106024-CA9EF774-1A91-40D3-A754-15CEABE9CA97Q34390831-C334387C-952B-4828-9B20-5EB3830E018FQ34420301-1064C7E2-4246-4BF7-8CF6-05DF1B05870CQ34594985-A342E9AA-BECF-477F-987B-AC330D4C7237Q34914187-1BC89227-5397-4213-98BC-A34A943B4EBFQ35021092-1A024756-BCBD-4FF8-A36B-02CC6110669FQ35051916-10EADF2E-018A-4DBC-A31A-9F43FB09DCD5Q35109871-2AD3D529-7F34-478A-8C22-55447BD399CFQ35162694-A5C8A0AC-4CFA-4A48-87AC-8EFAF78A216EQ35211629-6AB4F3B5-CD1C-498A-8871-476688F33EECQ35813050-2768BE38-2624-44C4-AFD5-6C8AF8645DD0Q35995832-BF11BD6C-BF7A-4949-8807-080F84506E2CQ36086056-DA07DBDD-0B4A-4440-A091-44829C466131Q36121296-91EA5FDD-2341-421A-9272-121A2869B502Q36237072-9CC06869-5C7E-454E-BC62-3359BC406C85Q36326057-2629780A-1716-4196-94C7-B8D83AC2AC95Q37407235-4B29F7C8-9631-46FE-B06C-E5AA04606E13Q37440346-2BBCBD32-6462-468D-89F6-2991E18652CCQ37482604-1C5D8FAC-6639-4756-88E7-D8211E010572Q37588160-D8A6CFE4-0CCA-4961-A761-E4948B0C968CQ38269204-3484C365-5047-4A46-9B5B-BFE98B0C1A66Q38440214-4C51F5C0-063B-43E1-9708-B45A81A46C62Q38446353-86ADF431-6958-485C-9A66-A4DA26E2EEDFQ38687620-7A5FB392-BED8-4F4B-8343-84283DD67945Q38751482-D704528F-3C85-48C7-8F31-6D9288996A48Q39153116-9031AB39-9ADD-4FD5-8157-582FA35171A3Q39974510-1F051EF4-B8D2-490E-9AD9-6AD44D98CFF9Q41643948-C93890E5-495B-4C5D-AE29-159426C522B2Q41835781-CFD07296-1C7C-45F1-96BB-C1EC1F768C01Q41871478-A04C07BC-9525-49BE-9AF3-53AFC11D3C1DQ42102903-127AA600-A5A6-4B4C-B511-79D874745B13Q42323740-C3971B65-7D62-49CC-AE70-233A22AE89D6Q42437926-7DACED1E-B804-490C-AD6B-C1CBEAB054AF
P2860
Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Clinicopathological and progno ...... /CT) in primary breast cancer.
@en
Clinicopathological and progno ...... uted tomography fusion imaging
@nl
type
label
Clinicopathological and progno ...... /CT) in primary breast cancer.
@en
Clinicopathological and progno ...... uted tomography fusion imaging
@nl
prefLabel
Clinicopathological and progno ...... /CT) in primary breast cancer.
@en
Clinicopathological and progno ...... uted tomography fusion imaging
@nl
P2093
P356
P1476
Clinicopathological and progno ...... /CT) in primary breast cancer.
@en
P2093
Hideki Asakawa
Hidetaka Mochizuki
Hitoshi Tsuda
Jiro Ishida
Katsumi Tamura
Kazuhiko Fukatsu
Mikio Yamamoto
Nobuo Kondo
Shigeto Ueda
Takashi Shigekawa
P304
P356
10.1093/JJCO/HYN019
P577
2008-04-01T00:00:00Z